COVID-19 and Asthma: What comments we need to know?

BACKGROUND: Asthma is a common chronic inflammatory respiratory disease more common in children. Microbial agents such as viruses are a common trigger of asthma. Coronavirus disease 2019 (COVID-19) is a pandemic disease that could lead to the exacerbation of allergic disorders such as asthma. The aim of this study is to write a narrative review of COVID-19 and asthma condition. METHODS: We searched in Google scholar, PubMed, and Scopus databases with keywords COVID-19, asthma, corticosteroid, and inhaled steroids. RESULTS: We found a few original articles on the combined subject of asthma and COVID-19. More than 50% of our data is expert comments at valid websites such as https://www.AAAAI.org or https://ginasthma.org. The typical treatment recommended in the exacerbation of asthma or chronic obstructive pulmonary disease (COPD) included the use of corticosteroids. The routine use of corticosteroids in patients with COVID19 without obstructive lung disease is not advised, as it may prolong viral replication. CONCLUSION: Patients with asthma need to continue on their preventive asthma medication, such as inhaled corticosteroids (ICS) in pandemic COVID-19.